Navigating Novel Uncertainties of COVID-19: The Rise of the JN.1 Variant.
| Autor: | Altamimi I; College of Medicine, King Saud University, Riyadh, SAU., Alabdulkarim IM; College of Medicine, King Saud University, Riyadh, SAU., Alhumimidi AS; College of Medicine, King Saud University, Riyadh, SAU., Albabtain MA; College of Medicine, King Saud University, Riyadh, SAU., Temsah MH; Pediatric Intensive Care Unit, College of Medicine, King Saud University, Riyadh, SAU.; Evidence-Based Healthcare and Knowledge Translation Research, King Saud University, Riyadh, SAU. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 Jan 02; Vol. 16 (1), pp. e51497. Date of Electronic Publication: 2024 Jan 02 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.51497 |
| Abstrakt: | In the shadow of the coronavirus disease 2019 (COVID-19) pandemic, the emergence of the JN.1 variant highlights the need for continued vigilance. This Editorial examines the characteristics of JN.1, derived from BA.2.86, and how it affects global public health. Despite its mutation on the spike protein and rapid spread, there has been no increase in disease severity, particularly in terms of ICU admissions, as evidenced by data from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). We emphasize the importance of continued surveillance, vaccine adaptation, and public health preparedness while advocating for a balanced response to effectively manage the post-pandemic era. It reflects on the resilience built through vaccination efforts and the need for international cooperation to navigate the way forward in the face of additional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Altamimi et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|